Evidence map›Paper›PMID 42709377›Full record

ReviewInternational journal of clinical oncology2026

From cell counts to cellular interactions: Cu-Cyto and the co-localization index as a spatial framework for the tumor immune microenvironment of rectal cancer.

Kimihiro Yamashita, Toru Nagasaka, Tomoki Abe, Yukari Adachi, Ryota Ito, Takaaki Tachibana, Toru Takahashi, Hiroki Kagiyama, Masaki Imai, Takao Tsuneki and 13 more

Abstract readReview
PubMed Publisher
In one paragraph

Review in International journal of clinical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Kimihiro YamashitaDivision of Gastrointestinal Surgery, Department of Surgery, Graduate School of Medicine, Kobe University, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe, Hyogo, 650-0017, Japan. kiyama@med.kobe-u.ac.jp.ORCID http://orcid.org/0000-0002-4208-7138
Toru NagasakaDivision of Gastrointestinal Surgery, Department of Surgery, Graduate School of Medicine, Kobe University, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe, Hyogo, 650-0017, Japan.
Tomoki AbeDivision of Gastrointestinal Surgery, Department of Surgery, Graduate School of Medicine, Kobe University, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe, Hyogo, 650-0017, Japan.
Yukari AdachiDivision of Gastrointestinal Surgery, Department of Surgery, Graduate School of Medicine, Kobe University, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe, Hyogo, 650-0017, Japan.
Ryota ItoDivision of Gastrointestinal Surgery, Department of Surgery, Graduate School of Medicine, Kobe University, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe, Hyogo, 650-0017, Japan.
Takaaki TachibanaDivision of Gastrointestinal Surgery, Department of Surgery, Graduate School of Medicine, Kobe University, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe, Hyogo, 650-0017, Japan.
Toru TakahashiDivision of Hepato-Biliary and Pancreatic Surgery, Department of Surgery, Graduate School of Medicine, Kobe University, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe, Hyogo, 650-0017, Japan.
Hiroki KagiyamaDivision of Gastrointestinal Surgery, Department of Surgery, Graduate School of Medicine, Kobe University, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe, Hyogo, 650-0017, Japan.
Masaki ImaiDivision of Gastrointestinal Surgery, Department of Surgery, Graduate School of Medicine, Kobe University, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe, Hyogo, 650-0017, Japan.
Takao TsunekiDivision of Gastrointestinal Surgery, Department of Surgery, Graduate School of Medicine, Kobe University, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe, Hyogo, 650-0017, Japan.
Masayuki AndoDivision of Gastrointestinal Surgery, Department of Surgery, Graduate School of Medicine, Kobe University, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe, Hyogo, 650-0017, Japan.
Yuna AsanoDivision of Biophysics, Department of Health Sciences, Graduate School of Medicine, Kobe University, 7-10-2 Tomogaoka, Suma-ku, Kobe, Hyogo, 654-0142, Japan.
Kumiko MiyashitaDivision of Biophysics, Department of Health Sciences, Graduate School of Medicine, Kobe University, 7-10-2 Tomogaoka, Suma-ku, Kobe, Hyogo, 654-0142, Japan.
Yasunori OtowaDivision of Gastrointestinal Surgery, Department of Surgery, Graduate School of Medicine, Kobe University, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe, Hyogo, 650-0017, Japan.
Naoki UrakawaDivision of Gastrointestinal Surgery, Department of Surgery, Graduate School of Medicine, Kobe University, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe, Hyogo, 650-0017, Japan.
Hironobu GotoDivision of Gastrointestinal Surgery, Department of Surgery, Graduate School of Medicine, Kobe University, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe, Hyogo, 650-0017, Japan.
Hiroshi HasegawaDivision of Gastrointestinal Surgery, Department of Surgery, Graduate School of Medicine, Kobe University, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe, Hyogo, 650-0017, Japan.
Shingo KanajiDivision of Gastrointestinal Surgery, Department of Surgery, Graduate School of Medicine, Kobe University, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe, Hyogo, 650-0017, Japan.
Mitsugu FujitaDivision of Gastrointestinal Surgery, Department of Surgery, Graduate School of Medicine, Kobe University, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe, Hyogo, 650-0017, Japan.
Takeru MatsudaDivision of Gastrointestinal Surgery, Department of Surgery, Graduate School of Medicine, Kobe University, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe, Hyogo, 650-0017, Japan.
Ryohei SasakiDivision of Radiation Oncology, Graduate School of Medicine, Kobe University, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe, Hyogo, 650-0017, Japan.
Takumi FukumotoDivision of Hepato-Biliary and Pancreatic Surgery, Department of Surgery, Graduate School of Medicine, Kobe University, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe, Hyogo, 650-0017, Japan.
Yoshihiro KakejiDivision of Gastrointestinal Surgery, Department of Surgery, Graduate School of Medicine, Kobe University, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe, Hyogo, 650-0017, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The tumor immune microenvironment in colorectal cancer has emerged as a major determinant of patient outcome, with tumor-infiltrating lymphocytes, particularly CD8⁺ T cells, mediating antitumor immunity. Standardized density-based metrics such as the Immunoscore have demonstrated prognostic value but cannot capture the spatial interactions among cells that underlie immune-tumor biology. We introduce a deep learning framework that integrates two complementary axes of analysis: Cu-Cyto, a deep learning-based image cytometry platform that detects and classifies approximately twenty cell types from standard immunohistochemistry-stained whole-slide images, using a bit-pattern kernel-filtering algorithm to prevent multi-counting and an off-target labeling strategy for precise nuclear-center localization; and the Co-Localization Index, which converts the classification probabilities and coordinates produced by Cu-Cyto into a single quantitative measure of co-localization between two or three cell types. We illustrate this framework through CD103⁺CD8⁺ tissue-resident memory-like T cells in rectal cancer treated with neoadjuvant chemoradiotherapy: their stromal but not intratumoral density independently predicts relapse-free survival. This divergence, which compartment-aware density alone cannot explain, motivates a metric that captures within-compartment spatial relationships. The Co-Localization Index extends naturally to three-cell interactions, providing a quantitative readout of the tri-cellular biology among CD103⁺CD8⁺ T cells, tumor cells, and stromal components. Prospective validation in independent rectal-cancer cohorts, addressing watch-and-wait organ preservation and adjuvant chemotherapy decisions, will determine whether this spatial-cellular framework translates into routine clinical decision support with potential extension to other solid tumor contexts.

Indexed as

CD103Co-localization indexDeep learningImage cytometryRectal cancerTumor immune microenvironment

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.